Market Research Logo

Global Biologics Market—Companies-to-Action

Global Biologics Market—Companies-to-Action

This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the growing demand for innovative therapies as well as the loss of patent exclusivity of the leading pharma products. Across therapy areas, oncology and diabetes emerge as the key contributing segments alongside immunology and cardiovascular diseases. Several small- to mid-sized companies are increasingly focusing on oncology and immunology segments which have high unmet needs and higher acceptability for innovative therapies. Furthermore, across the biologics sub-segments, monoclonal antibodies (mAb) and bioengineered vaccines are amongst the highest contributing segments, with most companies having a strong focus on developing a mAb pipeline. On the other hand, cell and gene therapy are expected to show a strong potential, especially across the rare diseases market, with leading companies like Amgen, Sanofi, Pfizer, etc., investing in molecules in the early stages of clinical development. These molecules, if approved, have the potential of becoming key blockbuster products, propelling the market by more than 20% in the next few years. To achieve expertise across specific therapy areas and biologic sub-segments, bio-pharma companies collaborate with Contract Development and Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs), and digital and medical equipment companies that provide access to innovative proprietary technologies for research and development activities and to optimize the manufacturing process of complex biologics. Alongside industry and academic research collaborations, companies are also focusing on partnering with IT players such as IBM Watson, Intel etc., which provide technologically advanced solutions for conducting clinical trials to support complex drug manufacturing processes, thus creating integrated business models in addition to the above mentioned strategic analysis, a detailed biologic product pipeline, and a SWOT analysis of the key players has been undertaken.

Some of the key questions answered by the study include:
• What are the current growth opportunities in biologics? What is the impact of the external environment on this market?
• Which are the leading companies that are introducing new and innovative products in the market?
• How do these companies intend to transform the industry paradigms in the next five years?
• What is their strategic focus and potential for growth?
• What are the key strategic imperatives in the biologics market?
• What are the key strategic collaborations/partnerships and investments made by the companies to stay on the growth trajectory?


  • Methodology
  • Executive Summary
    • Key Findings-Analysis of Companies-2-Action
    • Scope and Segmentation
    • Key Questions this Study will Answer
  • Companies-to-Action Overview
    • Companies to Action Value Creators
    • Opportunities and Threats
    • 10 Leading Biopharma Companies to Watch
  • Key Biologics Companies Product Pipeline Analysis-Roche: Biologic Product Pipeline Analysis
    • Roche-Product Portfolio Overview
      • Table Roche: Key Marketed Biologics, Global, 2016
    • Roche-Key Biologic Product Pipeline
    • Roche SWOT Analysis
  • Amgen-Biologic Product Pipeline Analysis
    • Amgen-Product Portfolio Overview
      • Table Amgen: Key Marketed Biologics, Global, 2016
    • Amgen-Key Biologic Product Pipeline
    • Amgen SWOT Analysis
  • Sanofi-Biologic Product Pipeline Analysis
    • Sanofi-Product Portfolio Overview
      • Table Sanofi: Key Marketed Biologics, Global, 2016
    • Sanofi-Key Biologic Product Pipeline
    • Sanofi SWOT Analysis
  • Abbvie-Biologic Product Pipeline Analysis
    • Abbvie-Product Portfolio Overview
      • Table Abbvie: Key Marketed Biologics, Global, 2016
    • Abbvie-Key Biologic Product Pipeline
    • Abbvie SWOT Analysis
  • Novo Nordisk-Biologic Product Pipeline Analysis
    • Novo Nordisk-Product Portfolio Overview
      • Table Novo Nordisk: Key Marketed Biologics, Global, 2016
    • Novo Nordisk-Key Biologic Product Pipeline
    • Novo Nordisk SWOT Analysis
  • Merck & Co.-Biologic Product Pipeline Analysis
    • Merck & Co-Product Portfolio Overview
      • Table Merck & Co: Key Marketed Biologics, Global, 2016
    • Merck & Co-Key Biologic Product Pipeline
    • Merck & Co SWOT Analysis
  • Pfizer-Biologic Product Pipeline Analysis
    • Pfizer-Product Portfolio Overview
      • Table Pfizer: Key Marketed Biologics, Global, 2016
    • Pfizer-Key Biologic Product Pipeline
    • Pfizer SWOT Analysis
  • Johnson & Johnson (JNJ)-Biologic Product Pipeline Analysis
    • JNJ-Product Portfolio Overview
      • Table Johnson & Johnson: Key Marketed Biologics, Global, 2016
    • JNJ-Key Biologic Product Pipeline
    • JNJ SWOT Analysis
  • Eli Lilly-Biologic Product Pipeline Analysis
    • Eli Lilly-Product Portfolio Overview
      • Table Eli Lilly: Key Marketed Biologics, Global, 2016
    • Eli Lilly-Key Biologic Product Pipeline
    • Eli Lilly SWOT Analysis
  • GlaxoSmithKline (GSK)-Biologic Product Pipeline Analysis
    • GlaxoSmithKline-Product Portfolio Overview
      • Table GlaxoSmithKline: Key Marketed Biologics, Global, 2016
    • GlaxoSmithKline-Key Biologic Product Pipeline
    • GlaxoSmithKline SWOT Analysis
  • Growth Environment-Business Models and Competitive Playbook
    • Business Models in Biologics Market
    • Competitive Playbook-Market Share Analysis
    • Top 10 Biologics in the Market
      • Table Total Biologics Market: Major Biologic Products, Global, 2016
    • Top 10 Biologics Companies
      • Table Total Biologics Market: Leading Biologic Companies, Global, 2015
    • Key Merger, Acquisition & Partnership Agreements
    • Key Investments and Facility Expansions
  • Growth Opportunities & Companies to Action
    • Transformation in Industry Ecosystem
    • 5 Major Growth Opportunities
    • Strategic Imperatives for Biologics Market
  • The Last Word
    • Conclusion-Key Take Aways
  • Appendix
    • List of Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report